VolitionRX Limited (NYSEAMERICAN:VNRX – Get Free Report) crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.28 and traded as low as $0.2660. VolitionRX shares last traded at $0.2850, with a volume of 6,574,460 shares trading hands.
VolitionRX Stock Up 13.5%
The business has a 50 day moving average price of $0.28 and a 200 day moving average price of $0.47. The stock has a market cap of $37.33 million, a PE ratio of -1.24 and a beta of 1.23.
VolitionRX Company Profile
VolitionRX, traded as VNRX on the NYSE American exchange, is a pioneering life sciences company focused on the development and commercialization of minimally invasive diagnostic tests for the early detection of cancer and other diseases. Utilizing proprietary technology to analyze circulating nucleosomes in blood samples, the company’s platform identifies disease-specific epigenetic and biochemical signatures. By offering blood-based screening solutions, VolitionRX aims to deliver alternatives to invasive, costly and time-consuming procedures, potentially improving patient outcomes through earlier diagnosis.
The company’s flagship product suite, branded as Nu.Q, comprises assays designed to detect biomarkers associated with a range of malignancies, including colorectal, lung and pancreatic cancers, as well as other systemic conditions.
Featured Articles
- Five stocks we like better than VolitionRX
- Stock market legend warns: “An Ominous Day Is Coming for the Markets…”
- Gold’s getting scarce.
- Trump’s Final Shocking Act Begins February 24
- NEW: Gold makes history
- Become a 2x better options trader (in 2 days)
Receive News & Ratings for VolitionRX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VolitionRX and related companies with MarketBeat.com's FREE daily email newsletter.
